gbli-10q_20180930.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[X]

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2018

OR

[   ]

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from                to               

001-34809

Commission File Number

 

GLOBAL INDEMNITY LIMITED

(Exact name of registrant as specified in its charter)

 

 

Cayman Islands

98-1304287

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer Identification No.)

27 HOSPITAL ROAD

GEORGE TOWN, GRAND CAYMAN

KY1-9008

CAYMAN ISLANDS

(Address of principal executive office including zip code)

Registrant's telephone number, including area code:  (345) 949-0100

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that registrant was required to submit such files.).  Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or emerging growth company.  See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

 

Large accelerated filer

[ ];

 

Accelerated filer

[X];

 

 

 

 

 

Non-accelerated filer

[ ];

 

Smaller reporting company

[ ];

 

 

 

 

 

Emerging growth company

[ ]

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes [ ] No [X]

As of November 2, 2018, the registrant had outstanding 10,089,507 A Ordinary Shares and 4,133,366 B Ordinary Shares.

 

 

 

 


TABLE OF CONTENTS

 

 

 

 

 

Page

 

PART I – FINANCIAL INFORMATION

 

 

 

 

 

 

 

Item 1.

 

Financial Statements:

 

3

 

 

 

 

 

 

 

Consolidated Balance Sheets
As of September 30, 2018 (Unaudited) and December 31, 2017

 

3

 

 

 

 

 

 

 

Consolidated Statements of Operations
Quarters and Nine Months Ended September 30, 2018 (Unaudited) and September 30, 2017 (Unaudited)

 

4

 

 

 

 

 

 

 

Consolidated Statements of Comprehensive Income
Quarters and Nine Months Ended September 30, 2018 (Unaudited) and September 30, 2017 (Unaudited)

 

5

 

 

 

 

 

 

 

Consolidated Statements of Changes in Shareholders’ Equity
Nine Months Ended September 30, 2018 (Unaudited) and Year Ended December 31, 2017

 

6

 

 

 

 

 

 

 

Consolidated Statements of Cash Flows
Nine Months Ended September 30, 2018 (Unaudited) and September 30, 2017 (Unaudited)

 

7

 

 

 

 

 

 

 

Notes to Consolidated Financial Statements (Unaudited)

 

8

 

 

 

 

 

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

52

 

 

 

 

 

Item 3.

 

Quantitative and Qualitative Disclosures about Market Risk

 

70

 

 

 

 

 

Item 4.

 

Controls and Procedures

 

71

 

 

 

 

 

PART II – OTHER INFORMATION

 

 

 

 

 

 

 

Item 1.

 

Legal Proceedings

 

72

 

 

 

 

 

Item 1A.

 

Risk Factors

 

72

 

 

 

 

 

Item 2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

 

72

 

 

 

 

 

Item 3.

 

Defaults Upon Senior Securities

 

72

 

 

 

 

 

Item 4.

 

Mine Safety Disclosures

 

72

 

 

 

 

 

Item 5.

 

Other Information

 

72

 

 

 

 

 

Item 6.

 

Exhibits

 

73

 

 

 

 

 

Signature

 

74

 

 

2


PART I – FINANCIAL INFORMATION

Item 1.  Financial Statements

GLOBAL INDEMNITY LIMITED

Consolidated Balance Sheets

(In thousands, except share amounts)

 

 

 

(Unaudited)

September 30, 2018

 

 

December 31, 2017

 

ASSETS

 

 

 

 

 

 

 

 

Fixed maturities:

 

 

 

 

 

 

 

 

Available for sale, at fair value (amortized cost: $1,299,656 and $1,243,144)

 

$

1,273,681

 

 

$

1,241,437

 

Equity securities:

 

 

 

 

 

 

 

 

At fair value (cost: $137,554 and $124,915)

 

 

137,554

 

 

 

140,229

 

Other invested assets

 

 

85,268

 

 

 

77,820

 

Total investments

 

 

1,496,503

 

 

 

1,459,486

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

40,646

 

 

 

74,414

 

Premiums receivable, net

 

 

84,641

 

 

 

84,386

 

Reinsurance receivables, net

 

 

96,534

 

 

 

105,060

 

Funds held by ceding insurers

 

 

50,805

 

 

 

45,300

 

Federal income taxes receivable

 

 

10,758

 

 

 

10,332

 

Deferred federal income taxes

 

 

35,675

 

 

 

26,196

 

Deferred acquisition costs

 

 

64,538

 

 

 

61,647

 

Intangible assets

 

 

22,152

 

 

 

22,549

 

Goodwill

 

 

6,521

 

 

 

6,521

 

Prepaid reinsurance premiums

 

 

22,976

 

 

 

28,851

 

Receivable for securities sold

 

 

-

 

 

 

1,543

 

Other assets

 

 

26,297

 

 

 

75,384

 

Total assets

 

$

1,958,046

 

 

$

2,001,669

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

Unpaid losses and loss adjustment expenses

 

$

608,607

 

 

$

634,664

 

Unearned premiums

 

 

297,630

 

 

 

285,397

 

Ceded balances payable

 

 

16,612

 

 

 

10,851

 

Payable for securities purchased

 

 

4,942

 

 

 

-

 

Contingent commissions

 

 

8,076

 

 

 

7,984

 

Debt

 

 

282,086

 

 

 

294,713

 

Other liabilities

 

 

37,767

 

 

 

49,666

 

Total liabilities

 

$

1,255,720

 

 

$

1,283,275

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies (Note 10)

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

Ordinary shares, $0.0001 par value, 900,000,000 ordinary shares authorized; A ordinary shares issued: 10,164,291 and 10,102,927 respectively; A ordinary shares outstanding: 10,089,507 and 10,073,376, respectively; B ordinary shares issued and outstanding: 4,133,366 and 4,133,366, respectively

 

 

2

 

 

 

2

 

Additional paid-in capital

 

 

437,124

 

 

 

434,730

 

Accumulated other comprehensive income (loss), net of taxes

 

 

(23,829

)

 

 

8,983

 

Retained earnings

 

 

292,001

 

 

 

275,838

 

A ordinary shares in treasury, at cost: 74,784 and 29,551 shares, respectively

 

 

(2,972

)

 

 

(1,159

)

Total shareholders’ equity

 

 

702,326

 

 

 

718,394

 

Total liabilities and shareholders’ equity

 

$

1,958,046

 

 

$

2,001,669

 

 

See accompanying notes to consolidated financial statements.

3


GLOBAL INDEMNITY LIMITED

Consolidated Statements of Operations

(In thousands, except shares and per share data)

 

 

 

(Unaudited)

Quarters Ended September 30,

 

 

(Unaudited)

Nine Months Ended September 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross premiums written

 

$

135,606

 

 

$

126,054

 

 

$

418,670

 

 

$

393,699

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net premiums written

 

$

116,233

 

 

$

109,045

 

 

$

360,557

 

 

$

344,348

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net premiums earned

 

$

120,528

 

 

$

108,619

 

 

$

342,447

 

 

$

328,818

 

Net investment income

 

 

11,750

 

 

 

10,134

 

 

 

34,108

 

 

 

27,618

 

Net realized investment gains (losses):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other than temporary impairment losses on investments

 

 

(24

)

 

 

(1,020

)

 

 

(395

)

 

 

(1,708

)

Other net realized investment gains

 

 

5,343

 

 

 

57

 

 

 

8,228

 

 

 

858

 

Total net realized investment gains (losses)

 

 

5,319

 

 

 

(963

)

 

 

7,833

 

 

 

(850

)

Other income

 

 

411

 

 

 

2,294

 

 

 

1,289

 

 

 

5,444

 

Total revenues

 

 

138,008

 

 

 

120,084

 

 

 

385,677

 

 

 

361,030

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Losses and Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net losses and loss adjustment expenses

 

 

80,493

 

 

 

82,395

 

 

 

195,426

 

 

 

202,656

 

Acquisition costs and other underwriting expenses

 

 

48,680

 

 

 

45,002

 

 

 

141,196

 

 

 

135,010

 

Corporate and other operating expenses

 

 

3,475

 

 

 

4,630

 

 

 

23,653

 

 

 

11,045

 

Interest expense

 

 

4,924

 

 

 

4,836

 

 

 

14,725

 

 

 

12,065

 

Income (loss) before income taxes

 

 

436

 

 

 

(16,779

)

 

 

10,677

 

 

 

254

 

Income tax benefit

 

 

(3,292

)

 

 

(7,855

)

 

 

(5,944

)

 

 

(13,193

)

Net income (loss)

 

$

3,728

 

 

$

(8,924

)

 

$

16,621

 

 

$

13,447

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Per share data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) (1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.26

 

 

$

(0.51

)

 

$

1.18

 

 

$

0.78

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted

 

$

0.26

 

 

$

(0.51

)

 

$

1.16

 

 

$

0.76

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

14,100,180

 

 

 

17,343,292

 

 

 

14,082,698

 

 

 

17,331,840

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted

 

 

14,346,585

 

 

 

17,343,292

 

 

 

14,321,113

 

 

 

17,684,519

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash dividends declared per share

 

$

0.25

 

 

$

-

 

 

$

0.75

 

 

$

-

 

 

(1) For the quarter ended September 30, 2017, “diluted” loss per share is the same as “basic” loss per share since there was a net loss for the period.

 

See accompanying notes to consolidated financial statements.

 

4


GLOBAL INDEMNITY LIMITED

Consolidated Statements of Comprehensive Income

(In thousands)

 

 

 

(Unaudited)

Quarters Ended September 30,

 

 

(Unaudited)

Nine Months Ended September 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Net income (loss)

 

$

3,728

 

 

$

(8,924

)

 

$

16,621

 

 

$

13,447

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized holding gains (losses)

 

 

(1,624

)

 

 

3,386

 

 

 

(22,632

)

 

 

10,719

 

Portion of other-than-temporary impairment losses

   recognized in other comprehensive income (losses)

 

 

7

 

 

 

(1

)

 

 

(1

)

 

 

(2

)

Reclassification adjustment for gains (losses) included in net income

 

 

717

 

 

 

441

 

 

 

1,403

 

 

 

(788

)

Unrealized foreign currency translation gains (losses)

 

 

(454

)

 

 

273

 

 

 

(1,554

)

 

 

774

 

Other comprehensive income (loss), net of tax

 

 

(1,354

)

 

 

4,099

 

 

 

(22,784

)

 

 

10,703

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive income (loss), net of tax

 

$

2,374

 

 

$

(4,825

)

 

$

(6,163

)

 

$

24,150

 

 

See accompanying notes to consolidated financial statements.

5


GLOBAL INDEMNITY LIMITED

Consolidated Statements of Changes in Shareholders’ Equity

(In thousands, except share amounts)

 

 

 

(Unaudited)

Nine Months Ended September 30, 2018

 

 

Year Ended

December 31, 2017

 

Number of A ordinary shares issued:

 

 

 

 

 

 

 

 

Number at beginning of period

 

 

10,102,927

 

 

 

13,436,548

 

Ordinary shares issued under share incentive plans

 

 

37,381

 

 

 

2,204

 

Ordinary shares issued to directors

 

 

23,983

 

 

 

27,121

 

Ordinary shares redeemed

 

 

-

 

 

 

(3,397,031

)

Adjustment for shares redeemed indirectly owned by subsidiary

 

 

-

 

 

 

34,085

 

Number at end of period

 

 

10,164,291

 

 

 

10,102,927

 

 

 

 

 

 

 

 

 

 

Number of B ordinary shares issued:

 

 

 

 

 

 

 

 

Number at beginning and end of period

 

 

4,133,366

 

 

 

4,133,366

 

 

 

 

 

 

 

 

 

 

Par value of A ordinary shares:

 

 

 

 

 

 

 

 

Number at beginning and end of period

 

$

1

 

 

$

1

 

 

 

 

 

 

 

 

 

 

Par value of B ordinary shares:

 

 

 

 

 

 

 

 

Balance at beginning and end of period

 

$

1

 

 

$

1

 

 

 

 

 

 

 

 

 

 

Additional paid-in capital:

 

 

 

 

 

 

 

 

Balance at beginning of period

 

$

434,730

 

 

$

430,283

 

Adjustment for shares redeemed indirectly owned by subsidiary

 

 

-

 

 

 

706

 

Share compensation plans

 

 

2,394

 

 

 

3,741

 

Balance at end of period

 

$

437,124

 

 

$

434,730

 

 

 

 

 

 

 

 

 

 

Accumulated other comprehensive income (loss), net of deferred income tax:

 

 

 

 

 

 

 

 

Balance at beginning of period

 

$

8,983

 

 

$

(618

)

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

Change in unrealized holding gains (losses)

 

 

(21,229

)

 

 

8,829

 

Change in other than temporary impairment losses recognized in other comprehensive income

 

 

(1

)

 

 

(3

)

Unrealized foreign currency translation gains  (losses)

 

 

(1,554

)

 

 

775

 

Other comprehensive income (loss)

 

 

(22,784

)

 

 

9,601

 

Cumulative effect adjustment resulting from adoption of new accounting guidance

 

 

(10,028

)

 

 

-

 

Balance at end of period

 

$

(23,829

)

 

$

8,983

 

 

 

 

 

 

 

 

 

 

Retained earnings:

 

 

 

 

 

 

 

 

Balance at beginning of period

 

$

275,838

 

 

$

368,284

 

Cumulative effect adjustment resulting from adoption of new accounting guidance

 

 

10,198

 

 

 

-

 

Ordinary shares redeemed

 

 

-

 

 

 

(83,015

)

Adjustment for gain on shares redeemed indirectly owned by subsidiary

 

 

-

 

 

 

120

 

Net income (loss)

 

 

16,621

 

 

 

(9,551

)

Dividends to shareholders

 

 

(10,656

)

 

 

-

 

Balance at end of period

 

$

292,001

 

 

$

275,838

 

 

 

 

 

 

 

 

 

 

Number of treasury shares:

 

 

 

 

 

 

 

 

Number at beginning of period

 

 

29,551

 

 

 

-

 

A ordinary shares purchased

 

 

45,233

 

 

 

29,551

 

Number at end of period

 

 

74,784

 

 

 

29,551

 

 

 

 

 

 

 

 

 

 

Treasury shares, at cost:

 

 

 

 

 

 

 

 

Balance at beginning of period

 

$

(1,159

)

 

$

-

 

A ordinary shares purchased, at cost

 

 

(1,813

)

 

 

(1,159

)

Balance at end of period

 

$

(2,972

)

 

$

(1,159

)

Total shareholders’ equity

 

$

702,326

 

 

$

718,394

 

 

See accompanying notes to consolidated financial statements.

6


GLOBAL INDEMNITY LIMITED

Consolidated Statements of Cash Flows

(In thousands)

 

 

 

(Unaudited)

Nine Months Ended September 30,

 

 

 

2018

 

 

2017

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net income

 

$

16,621

 

 

$

13,447

 

Adjustments to reconcile net income to net cash provided by (used for) operating activities:

 

 

 

 

 

 

 

 

Amortization and depreciation

 

 

5,272

 

 

 

4,813

 

Amortization of debt issuance costs

 

 

198

 

 

 

166

 

Restricted stock and stock option expense

 

 

2,394

 

 

 

2,971

 

Deferred federal income taxes

 

 

(6,270

)

 

 

(13,611

)

Amortization of bond premium and discount, net

 

 

4,650

 

 

 

6,137

 

Net realized investment (gains) losses

 

 

(7,833

)

 

 

850

 

Changes in:

 

 

 

 

 

 

 

 

Premiums receivable, net

 

 

(255

)

 

 

7,632

 

Reinsurance receivables, net

 

 

8,526

 

 

 

20,005

 

Funds held by ceding insurers

 

 

(7,059

)

 

 

(26,576

)

Unpaid losses and loss adjustment expenses

 

 

(26,057

)

 

 

(1,316

)

Unearned premiums

 

 

12,233

 

 

 

3,776

 

Ceded balances payable

 

 

5,761

 

 

 

(1,808

)

Other assets and liabilities, net

 

 

35,040

 

 

 

(31,442

)

Contingent commissions

 

 

92

 

 

 

(3,902

)

Federal income tax receivable/payable

 

 

(426

)

 

 

314

 

Deferred acquisition costs, net

 

 

(2,891

)

 

 

(4,396

)

Prepaid reinsurance premiums

 

 

5,875

 

 

 

11,756

 

Net cash provided by (used for) operating activities

 

 

45,871

 

 

 

(11,184

)

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Proceeds from sale of fixed maturities

 

 

229,362

 

 

 

742,229

 

Proceeds from sale of equity securities

 

 

28,141

 

 

 

24,483

 

Proceeds from maturity of fixed maturities

 

 

43,303

 

 

 

112,620

 

Proceeds from limited partnerships

 

 

8,352

 

 

 

10,567

 

Amounts received (paid) in connection with derivatives

 

 

7,599

 

 

 

(2,500

)

Purchases of fixed maturities

 

 

(329,002

)

 

 

(979,074

)

Purchases of equity securities

 

 

(22,931

)

 

 

(28,631

)

Purchases of other invested assets

 

 

(15,800

)

 

 

(18,000

)

Acquisition of business

 

 

(3,515

)

 

 

-

 

Net cash used for investing activities

 

 

(54,491

)

 

 

(138,306

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Net borrowings (repayments) under margin borrowing facility

 

 

(12,825

)

 

 

9,872

 

Proceeds from issuance of subordinated notes

 

 

-

 

 

 

130,000

 

Debt issuance cost

 

 

-

 

 

 

(4,246

)

Dividends paid to shareholders

 

 

(10,510

)

 

 

-

 

Purchase of A ordinary shares

 

 

(1,813

)

 

 

(1,159

)

Net cash provided by (used for) financing activities

 

 

(25,148

)

 

 

134,467

 

Net change in cash and cash equivalents

 

 

(33,768

)

 

 

(15,023

)

Cash and cash equivalents at beginning of period

 

 

74,414

 

 

 

75,110

 

Cash and cash equivalents at end of period

 

$

40,646

 

 

$

60,087

 

See accompanying notes to consolidated financial statements.

 

7


GLOBAL INDEMNITY LIMITED

1.

Principles of Consolidation and Basis of Presentation

Global Indemnity Limited (“Global Indemnity” or “the Company”) was incorporated on February 9, 2016 and is domiciled in the Cayman Islands.  On November 7, 2016, Global Indemnity replaced Global Indemnity plc as the ultimate parent company as a result of a redomestication transaction.  The Company’s A ordinary shares are publicly traded on the NASDAQ Global Select Market under the ticker symbol GBLI.  Please see Note 2 of the notes to the consolidated financial statements in Item 8 Part II of the Company’s 2017 Annual Report on Form 10-K for more information on the Company’s redomestication.

The Company manages its business through three business segments:  Commercial Lines, Personal Lines, and Reinsurance Operations.  The Company’s Commercial Lines offers specialty property and casualty insurance products in the excess and surplus lines marketplace.  The Company manages its Commercial Lines by differentiating them into four product classifications: Penn-America, which markets property and general liability products to small commercial businesses through a select network of wholesale general agents with specific binding authority; United National, which markets insurance products for targeted insured segments, including specialty products, such as property, general liability, and professional lines through program administrators with specific binding authority; Diamond State, which markets property, casualty, and professional lines products, which are developed by the Company’s underwriting department by individuals with expertise in those lines of business, through wholesale brokers and also markets through program administrators having specific binding authority; and Vacant Express, which insures dwellings which are currently vacant, undergoing renovation, or are under construction and is distributed through aggregators, brokers, and retail agents. These product classifications comprise the Company’s Commercial Lines business segment and are not considered individual business segments because each product has similar economic characteristics, distribution, and coverage. The Company’s Personal Lines segment offers specialty personal lines and agricultural coverage through general and specialty agents with specific binding authority on an admitted basis.  Collectively, the Company’s U.S. insurance subsidiaries are licensed in all 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands. The Commercial Lines and Personal Lines segments comprise the Company’s U.S. Insurance Operations (‘Insurance Operations”).   The Company’s Reinsurance Operations consist solely of the operations of its Bermuda-based wholly-owned subsidiary, Global Indemnity Reinsurance Company, Ltd. (“Global Indemnity Reinsurance”).  Global Indemnity Reinsurance is a treaty reinsurer of specialty property and casualty insurance and reinsurance companies.  The Company’s Reinsurance Operations segment provides reinsurance solutions through brokers and primary writers including insurance and reinsurance companies.  

The interim consolidated financial statements are unaudited, but have been prepared in conformity with United States of America generally accepted accounting principles (“GAAP”), which differs in certain respects from those principles followed in reports to insurance regulatory authorities.  The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

The unaudited consolidated financial statements include all adjustments that are, in the opinion of management, of a normal recurring nature and are necessary for a fair statement of results for the interim periods.  Results of operations for the quarters and nine months ended September 30, 2018 and 2017 are not necessarily indicative of the results of a full year.  The accompanying notes to the unaudited consolidated financial statements should be read in conjunction with the notes to the consolidated financial statements contained in the Company’s 2017 Annual Report on Form 10-K.

On January 1, 2018, the Company adopted new accounting guidance which requires equity investments, except for those accounted for under the equity method of accounting or those that result in consolidation of the investee, to be measured at fair value with the changes in fair value recognized in net income.  Upon adoption, the Company recorded a cumulative effect adjustment, net of tax, of $10.0 million which reduced accumulated other comprehensive income and increased retained earnings.  During the quarter and nine months ended September 30, 2018, net realized investment gains (losses) included a gain of $2.7 million and a loss of $1.4 million, respectively, related to the change in the fair value of equity investments in accordance with this new accounting guidance.  In addition, under the new guidance, equity investments, are no longer classified into different categories as either trading or available for sale.  Prior to the adoption of this new guidance, equity securities were previously classified as available for sale.

8


GLOBAL INDEMNITY LIMITED

On January 1, 2018, the Company adopted new accounting guidance regarding the classification of certain cash receipts and cash payments within the statement of cash flows.  Upon adoption, the Company made a policy election to use the cumulative earnings approach for presenting distributions received from equity method investees.  Under this approach, distributions up to the amount of cumulative equity in earnings recognized will be treated as returns on investment and presented in operating activities and those in excess of that amount will be treated as returns of investment and presented in the investing section.  Prior to adoption, all distributions received from equity method investees were presented in the investing section of the consolidated statements of cash flows.  The provisions of this accounting guidance were adopted on a retrospective basis.  As a result, the consolidated statement of cash flows for the nine months ended September 30, 2017 that was included in the Form 10-Q for the nine months ended September 30, 2017 was restated.  For the nine months ended September 30, 2017, net cash flows from operating activities was increased by $2.4 million and net cash flows from investing activities was reduced by $2.4 million.  

The consolidated financial statements include the accounts of Global Indemnity and its wholly owned subsidiaries.  All intercompany balances and transactions have been eliminated in consolidation.

 

2.

Investments

The amortized cost and estimated fair value of investments were as follows as of September 30, 2018 and December 31, 2017:

(Dollars in thousands)

 

Amortized

Cost

 

 

Gross

Unrealized

Gains

 

 

Gross

Unrealized

Losses

 

 

Estimated

Fair Value

 

 

Other than

temporary

impairments

recognized

in AOCI (1)

 

As of September 30, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. treasury and agency obligations

 

$

81,565

 

 

$

156

 

 

$

(2,051

)

 

$

79,670

 

 

$

-

 

Obligations of states and political subdivisions

 

 

100,494

 

 

 

131

 

 

 

(998

)

 

 

99,627

 

 

 

-

 

Mortgage-backed securities

 

 

138,442

 

 

 

280

 

 

 

(3,878

)

 

 

134,844

 

 

 

-

 

Asset-backed securities

 

 

201,317

 

 

 

46

 

 

 

(1,641

)

 

 

199,722

 

 

 

(1

)

Commercial mortgage-backed securities

 

 

186,081

 

 

 

3

 

 

 

(5,876

)

 

 

180,208

 

 

 

-

 

Corporate bonds

 

 

466,198

 

 

 

235

 

 

 

(9,601

)

 

 

456,832

 

 

 

-

 

Foreign corporate bonds

 

 

125,559

 

 

 

33

 

 

 

(2,814

)

 

 

122,778

 

 

 

-

 

Total fixed maturities

 

 

1,299,656

 

 

 

884

 

 

 

(26,859

)

 

 

1,273,681

 

 

 

(1

)

Common stock

 

 

137,554

 

 

 

-

 

 

 

-

 

 

 

137,554

 

 

 

-

 

Other invested assets

 

 

85,268

 

 

 

-

 

 

 

-

 

 

 

85,268

 

 

 

-

 

Total

 

$

1,522,478

 

 

$

884

 

 

$

(26,859

)

 

$

1,496,503

 

 

$

(1

)

 

(1)

Represents the total amount of other than temporary impairment losses relating to factors other than credit losses recognized in accumulated other comprehensive income (“AOCI”).

9


GLOBAL INDEMNITY LIMITED

 

(Dollars in thousands)

 

Amortized

Cost

 

 

Gross

Unrealized

Gains

 

 

Gross

Unrealized

Losses

 

 

Estimated

Fair Value

 

 

Other than

temporary

impairments

recognized

in AOCI (1)

 

As of December 31, 2017